首页 > 市场调查报告书 > 製药

感染疾病

市场调查报告书

商品编码

1477512

狂犬病兽用疫苗市场 - 全球产业规模、份额、趋势、机会和预测，按应用（伴侣动物、家畜、野生动物）区域和竞争细分，2019-2029F

Rabies Veterinary Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application (Companion Animals, Livestock Animals, Wildlife Animals) Region and Competition, 2019-2029F

出版日期: 2024年05月06日 | 出版商:

TechSci Research | 英文 183 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2023 年全球狂犬病兽用疫苗市场价值为5.5036 亿美元，预计在预测期内将强劲增长，到2029 年复合年增长率为4.75%。部分，致力于预防和控制狂犬病的传播，狂犬病是一种影响包括人类在内的哺乳动物的致命病毒性疾病。该市场包括一系列专为兽医用途设计的疫苗，旨在使家畜和野生动物对狂犬病病毒进行免疫。狂犬病从受感染动物传播给人类相关的重大公共卫生问题刺激了对狂犬病兽用疫苗的需求，这凸显了从源头控制疾病的重要性。市场成长受到多种因素的推动，包括政府要求宠物和牲畜接种狂犬病疫苗、宠物主人和兽医专业人员意识的提高以及全球狂犬病病例发病率的上升。此外，宠物数量的不断增加，特别是在城市地区，导致对狂犬病疫苗的需求不断增长。该市场的製造商专注于开发安全有效的疫苗，采用先进的生物技术方法来提高疫苗的功效和免疫力的持续时间。

市场概况
预测期	2025-2029
2023 年市场规模	55036万美元
2029 年市场规模	7.2872亿美元
2024-2029 年复合年增长率	4.75%
成长最快的细分市场	伴侣动物
最大的市场	北美洲

疫苗製造商与政府或非政府组织之间的策略合作促进了疫苗在流行地区的分发，并支持针对狂犬病病毒野生动物宿主的疫苗接种活动。市场上也见证了野生动物口服狂犬病疫苗等创新，旨在控制浣熊、狐狸和蝙蝠等宿主物种的疾病，从而降低传播给家畜和人类的风险。从地理位置来看，市场动态各不相同，狂犬病发病率较高的地区推动了对兽用疫苗的大量需求。

儘管透过疫苗接种计划在狂犬病预防方面取得了重大进展，但挑战仍然存在，包括偏远或资源有限地区获得疫苗的机会有限、疫苗储存和分配物流以及一些动物主人对疫苗犹豫不决。然而，疫苗技术的不断进步，加上各国政府、国际组织和兽医保健提供者的共同努力，预计将维持全球狂犬病兽用疫苗市场的成长，最终有助于全球消除狂犬病这一公共卫生威胁。

主要市场驱动因素

提高认识和教育

政府措施和法规

狂犬病病例发生率上升

主要市场挑战

偏远地区获得疫苗的机会有限

疫苗储存及配送物流

疫苗接种计划成本高昂

主要市场趋势

疫苗开发的技术进步

宠物拥有量的增加和人与动物之间的联繫

细分市场洞察

应用洞察

区域洞察

Global Rabies Veterinary Vaccines Market was valued at USD 550.36 million in 2023 and is anticipated to project robust growth in the forecast period with a CAGR of 4.75% through 2029. The Global Rabies Veterinary Vaccines Market is a vital component of the broader animal healthcare industry, dedicated to preventing and controlling the transmission of rabies, a lethal viral disease that affects mammals, including humans. This market encompasses a range of vaccines specifically designed for veterinary use, aimed at immunizing domestic animals and wildlife against the rabies virus. The demand for rabies veterinary vaccines is fueled by the significant public health concern associated with rabies transmission from infected animals to humans, underscoring the importance of controlling the disease at its source. Market growth is driven by various factors, including government mandates requiring rabies vaccination in pets and livestock, increasing awareness among pet owners and veterinary professionals, and the rising incidence of rabies cases globally. Additionally, the expanding pet population, particularly in urban areas, contributes to the growing demand for rabies vaccines. Manufacturers within this market focus on developing safe and effective vaccines, employing advanced biotechnological methods to enhance vaccine efficacy and duration of immunity.

Market Overview
Forecast Period	2025-2029
Market Size 2023	USD 550.36 Million
Market Size 2029	USD 728.72 Million
CAGR 2024-2029	4.75%
Fastest Growing Segment	Companion Animals
Largest Market	North America

Strategic collaborations between vaccine manufacturers and governmental or non-governmental organizations facilitate vaccine distribution in endemic regions and support vaccination campaigns targeting wildlife reservoirs of the rabies virus. The market also witnesses innovations such as oral rabies vaccines for wildlife, aimed at controlling the disease in reservoir species like raccoons, foxes, and bats, thereby reducing the risk of transmission to domestic animals and humans. Geographically, the dynamics of the market vary, with regions experiencing higher incidences of rabies driving substantial demand for veterinary vaccines.

Despite significant progress in rabies prevention through vaccination programs, challenges persist, including limited access to vaccines in remote or resource-constrained regions, vaccine storage and distribution logistics, and vaccine hesitancy among some animal owners. However, ongoing advancements in vaccine technology, coupled with concerted efforts from governments, international organizations, and veterinary healthcare providers, are expected to sustain the growth of the Global Rabies Veterinary Vaccines Market, ultimately contributing to the global elimination of rabies as a public health threat.

Key Market Drivers

Increasing Awareness and Education

Increasing awareness and education play a crucial role in boosting the Global Rabies Veterinary Vaccines Market. As knowledge about the risks associated with rabies transmission grows among pet owners, animal health professionals, and the general public, there is a corresponding increase in demand for rabies vaccines. Educational campaigns and outreach programs conducted by governmental and non-governmental organizations are instrumental in disseminating information about the importance of rabies vaccination in preventing the disease.

One of the key drivers behind the rising awareness is the recognition of rabies as a significant public health threat. Governments and health organizations worldwide have been actively involved in raising awareness about the dangers of rabies and the importance of vaccination. These efforts often include public health campaigns, educational materials distributed in schools and communities, and collaborations with veterinary professionals to promote vaccination programs. As a result, pet owners become more conscious of the need to vaccinate their animals, leading to an increased demand for rabies vaccines in the veterinary market.

Advancements in communication technology have facilitated the dissemination of information about rabies prevention and vaccination. Social media platforms, websites, and mobile applications provide accessible resources for pet owners to learn about rabies and vaccination schedules for their animals. Veterinary clinics and animal shelters also play a vital role in educating pet owners about rabies prevention during routine check-ups and adoption processes. In addition to raising awareness among pet owners, educational initiatives target veterinary professionals to ensure they are equipped with the knowledge and resources to effectively promote rabies vaccination. Continuing education programs, seminars, and conferences provide veterinarians with updates on rabies prevention protocols, vaccine advancements, and best practices for vaccination campaigns. By empowering veterinary professionals with the necessary skills and information, these initiatives contribute to the widespread adoption of rabies vaccination in domestic animals.

Increasing awareness about the benefits of rabies vaccination extends beyond domestic pets to include wildlife populations. Efforts to control rabies in wildlife reservoirs through vaccination campaigns contribute to overall disease prevention and reduce the risk of transmission to domestic animals and humans. Through collaborative efforts between governmental agencies, conservation organizations, and veterinary professionals, educational campaigns raise awareness about the importance of wildlife vaccination programs, further driving the demand for rabies veterinary vaccines in the global market.

Government Initiatives and Regulations

Government initiatives and regulations play a pivotal role in boosting the Global Rabies Veterinary Vaccines Market by mandating vaccination programs and implementing policies aimed at controlling the spread of rabies. Many countries have recognized rabies as a significant public health concern and have taken proactive measures to address it. One of the primary drivers behind the demand for rabies veterinary vaccines is the implementation of mandatory vaccination programs for domestic animals, including dogs, cats, and livestock. These programs typically require pet owners to ensure their animals are vaccinated against rabies regularly. Such regulations not only protect animal health but also help prevent the transmission of the virus to humans, thereby driving the demand for rabies vaccines in the veterinary market.

Government initiatives often involve funding and support for vaccination campaigns, particularly in regions where rabies is endemic. These campaigns aim to vaccinate a large percentage of the animal population to establish herd immunity and reduce the risk of rabies transmission. Governments may provide subsidies or free vaccination clinics to make vaccines more accessible to pet owners, further stimulating demand for rabies veterinary vaccines. In addition to vaccination programs, governments implement regulations to control the movement of animals, particularly those at high risk of transmitting rabies. Quarantine measures and restrictions on importing animals from rabies-endemic regions help prevent the introduction of the virus into rabies-free areas, contributing to disease prevention efforts. These regulations often mandate proof of rabies vaccination as a requirement for animal importation, driving the demand for vaccines among breeders, traders, and pet owners involved in international animal trade.

Government agencies collaborate with veterinary professionals, research institutions, and non-governmental organizations to develop and implement comprehensive strategies for rabies control and prevention. These collaborations may involve the distribution of educational materials, training programs for veterinary personnel, and surveillance efforts to monitor rabies outbreaks and trends. By coordinating efforts across multiple sectors, governments can effectively address the challenges posed by rabies and promote the widespread adoption of rabies vaccination in domestic animals and wildlife populations.

Rising Incidence of Rabies Cases

The rising incidence of rabies cases globally serves as a significant driver in boosting the Global Rabies Veterinary Vaccines Market. Despite concerted efforts to control and eliminate rabies, the disease continues to pose a serious public health threat, particularly in regions where it is endemic, such as parts of Asia and Africa. The increase in reported cases of rabies highlights the urgent need for effective prevention measures, including vaccination of domestic animals and wildlife.

One of the primary factors contributing to the rising incidence of rabies cases is the expanding human population, leading to increased interactions between humans, domestic animals, and wildlife. As urbanization encroaches into natural habitats, humans and animals come into closer contact, increasing the risk of rabies transmission. Furthermore, population growth often leads to the proliferation of stray animals, such as dogs and cats, which can serve as reservoirs for the rabies virus and contribute to its spread within communities. Additionally, factors such as inadequate access to healthcare services, limited awareness about rabies prevention, and insufficient resources for vaccination programs exacerbate the problem in many regions. As a result, the number of rabies cases continues to rise, underscoring the importance of vaccination as a primary strategy for disease control.

In response to the growing incidence of rabies cases, governments and health organizations are ramping up efforts to expand rabies vaccination programs for both domestic animals and wildlife. Vaccination campaigns targeting high-risk areas and populations help curb the spread of the virus and prevent outbreaks. Furthermore, advancements in vaccine technology, such as the development of more affordable and heat-stable vaccines, make vaccination programs more accessible and sustainable in resource-limited settings.

The rising incidence of rabies cases has prompted increased public awareness about the importance of rabies vaccination for pets. Pet owners are becoming more proactive in vaccinating their animals against rabies to protect their health and prevent transmission to humans. This heightened awareness contributes to the growing demand for rabies veterinary vaccines in the market.

Key Market Challenges

Limited Access to Vaccines in Remote Regions

One of the significant challenges hindering the Global Rabies Veterinary Vaccines Market is the limited access to vaccines in remote or resource-constrained regions where rabies is prevalent. These areas often lack adequate healthcare infrastructure, including veterinary clinics and distribution networks, making it difficult to deliver vaccines to animal populations in need. Additionally, transportation logistics, cold chain requirements for vaccine storage, and socioeconomic factors further exacerbate the challenges of vaccine distribution in remote regions.

Vaccine Storage and Distribution Logistics

Vaccine storage and distribution logistics pose another significant challenge for the Global Rabies Veterinary Vaccines Market. Rabies vaccines require strict temperature control to maintain their efficacy, necessitating cold chain infrastructure throughout the distribution process. In regions with unreliable electricity or inadequate refrigeration facilities, maintaining the cold chain becomes particularly challenging, leading to vaccine wastage and reduced effectiveness. Improving vaccine storage and distribution logistics is essential to ensure vaccines reach their intended recipients and maintain their potency.

High Cost of Vaccination Programs

The high cost of vaccination programs poses a significant barrier to rabies prevention efforts, particularly in low-income countries and resource-limited settings. The cost of purchasing vaccines, establishing vaccination clinics, and deploying trained personnel can strain already limited healthcare budgets, hindering the implementation of widespread vaccination campaigns. Additionally, the recurring nature of vaccination requirements for maintaining immunity further compounds the financial burden on animal owners and healthcare providers.

Key Market Trends

Technological Advancements in Vaccine Development

Technological advancements in vaccine development are playing a pivotal role in boosting the Global Rabies Veterinary Vaccines Market. As the veterinary healthcare industry embraces cutting-edge technologies, there has been a significant impact on the development of safer, more efficacious vaccines against rabies. These advancements have revolutionized vaccine design, production, and delivery, leading to improved outcomes in rabies prevention efforts worldwide.

One of the key advancements driving the Global Rabies Veterinary Vaccines Market is the use of recombinant DNA technology. This technology allows researchers to manipulate the genetic material of organisms, enabling the production of recombinant rabies antigens for vaccine formulation. Recombinant vaccines offer several advantages over traditional vaccines, including improved safety, reduced risk of adverse reactions, and increased stability. By leveraging recombinant DNA technology, manufacturers can develop vaccines with enhanced immunogenicity and efficacy, providing better protection against rabies infection in animals.

Advancements in adjuvant formulations have contributed to the effectiveness of rabies veterinary vaccines. Adjuvants are substances added to vaccines to enhance the immune response and improve vaccine efficacy. Novel adjuvant formulations, such as liposomes, nanoparticles, and toll-like receptor agonists, stimulate robust immune responses, leading to better protection against rabies virus infection. These advancements in adjuvant technology have allowed for the development of next-generation rabies vaccines with improved performance and duration of immunity.

Advancements in vaccine delivery methods are driving innovation in the Global Rabies Veterinary Vaccines Market. Traditional vaccine delivery methods, such as injectable vaccines, remain effective but may pose challenges in terms of administration and compliance. Novel vaccine delivery systems, such as oral vaccines and intranasal vaccines, offer non-invasive and convenient alternatives for rabies vaccination in animals. Oral rabies vaccines, in particular, have been successfully used in wildlife vaccination programs, where bait containing vaccine baits are distributed to target species, resulting in widespread immunization and disease control.

Rising Pet Ownership and Human-Animal Bond

The Global Rabies Veterinary Vaccines Market is experiencing a significant boost from the rising trend of pet ownership and the strengthening human-animal bond. As more people around the world welcome pets into their homes and lives, there is a corresponding increase in the demand for veterinary healthcare services, including rabies vaccination. One of the primary factors driving the Global Rabies Veterinary Vaccines Market is the increasing number of pet owners who prioritize their animals' health and well-being. Pets are often considered cherished members of the family, and pet owners are willing to invest in preventive healthcare measures to ensure their pets lead healthy, happy lives. Rabies vaccination is a crucial aspect of preventive care, as it protects pets from a deadly viral disease and prevents transmission to humans.

The human-animal bond plays a significant role in boosting the demand for rabies veterinary vaccines. Research has shown that pet ownership has numerous physical, emotional, and social benefits for humans, including reduced stress, improved mood, and increased social interaction. The strong emotional connection between pet owners and their animals motivates pet owners to prioritize their pets' health and seek out preventive healthcare services, such as vaccination.

The COVID-19 pandemic has further accelerated the trend of pet ownership and strengthened the human-animal bond. During lockdowns and periods of social distancing, many people turned to pets for companionship, comfort, and emotional support. As a result, there has been a surge in pet adoptions and acquisitions, leading to an expansion of the pet population worldwide. This increase in pet ownership has translated into a higher demand for veterinary services, including rabies vaccination, as pet owners prioritize their animals' health and well-being.

The growing awareness of zoonotic diseases, such as rabies, has heightened the importance of preventive measures in veterinary healthcare. Pet owners are increasingly aware of the potential risks of zoonotic diseases to both animal and human health, driving the demand for rabies vaccination as a preventive measure. By vaccinating their pets against rabies, pet owners not only protect their animals from a life-threatening disease but also contribute to public health efforts to prevent the spread of rabies to humans. rising pet ownership and the strengthening human-animal bond are significant drivers boosting the Global Rabies Veterinary Vaccines Market. As more people welcome pets into their homes and lives, there is a corresponding increase in the demand for rabies vaccination and other veterinary healthcare services.

Segmental Insights

Application Insights

Based on the Application, companion animals segment emerged as the dominant segment in the Global Rabies Veterinary Vaccines Market in 2023. This trend can be attributed to several factors that have contributed to the growing demand for rabies vaccines in companion animals, such as dogs and cats. The rising trend of pet ownership worldwide has significantly increased the demand for rabies vaccination in companion animals. Pets are considered cherished members of the family, and pet owners prioritize their animals' health and well-being. As a result, there has been a surge in the number of pet owners seeking preventive healthcare services for their pets, including rabies vaccination. Additionally, the strengthening human-animal bond has further fueled the demand for rabies vaccines in companion animals.

Regional Insights

North America emerged as the dominant region in the Global Rabies Veterinary Vaccines Market in 2023, holding the largest market share. stringent government regulations and vaccination mandates in North America have significantly contributed to the region's dominance in the market. Many countries within North America, including the United States and Canada, have implemented mandatory rabies vaccination laws for domestic animals, such as dogs and cats. These regulations require pet owners to ensure their animals are vaccinated against rabies regularly, driving a consistent demand for veterinary vaccines in the region. The dominance of North America in the Global Rabies Veterinary Vaccines Market in 2023 underscores the region's commitment to rabies prevention, strong regulatory framework, advanced healthcare infrastructure, and growing pet ownership culture.

Key Market Players

Merck & Co., Inc. (MSD Animal Health)

Indian Immunologicals Ltd.

Boehringer Ingelheim International GmbH (Animal Health)

Zoetis Inc

Virbac S.A.

BroadChem Philippines Biopharma Corporation

Elanco Animal Health Inc.

Ceva Sante Animale S.A.

BiogenesisBago. S.A.

Sanofi SA

Report Scope:

In this report, the Global Rabies Veterinary Vaccines Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Rabies Veterinary Vaccines Market, By Application:

Companion Animals Livestock Animals Wildlife Animals

Rabies Veterinary Vaccines Market, By Region:

North America

United States

Canada

Mexico

Europe

France

United Kingdom

Italy

Germany

Spain

Asia-Pacific

China

India

Japan

Australia

South Korea

South America

Brazil

Argentina

Colombia

Middle East & Africa

South Africa

Saudi Arabia

UAE

Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Rabies Veterinary Vaccines Market.

Available Customizations:

Global Rabies Veterinary Vaccines Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Rabies Veterinary Vaccines Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Application (Companion Animals, Livestock Animals, Wildlife Animals)
- 5.2.2. By Region
- 5.2.3. By Company (2023)
5.3. Market Map
- 5.3.1. By Application
- 5.3.2. By Region

6. Asia Pacific Rabies Veterinary Vaccines Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Application
- 6.2.2. By Country
6.3. Asia Pacific: Country Analysis
- 6.3.1. China Rabies Veterinary Vaccines Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Application
- 6.3.2. India Rabies Veterinary Vaccines Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Application
- 6.3.3. Australia Rabies Veterinary Vaccines Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Application
- 6.3.4. Japan Rabies Veterinary Vaccines Market Outlook
  - 6.3.4.1. Market Size & Forecast
    - 6.3.4.1.1. By Value
  - 6.3.4.2. Market Share & Forecast
    - 6.3.4.2.1. By Application
- 6.3.5. South Korea Rabies Veterinary Vaccines Market Outlook
  - 6.3.5.1. Market Size & Forecast
    - 6.3.5.1.1. By Value
  - 6.3.5.2. Market Share & Forecast
    - 6.3.5.2.1. By Application

7. Europe Rabies Veterinary Vaccines Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Application
- 7.2.2. By Country
7.3. Europe: Country Analysis
- 7.3.1. France Rabies Veterinary Vaccines Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Application
- 7.3.2. Germany Rabies Veterinary Vaccines Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Application
- 7.3.3. Spain Rabies Veterinary Vaccines Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Application
- 7.3.4. Italy Rabies Veterinary Vaccines Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Application
- 7.3.5. United Kingdom Rabies Veterinary Vaccines Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Application

8. North America Rabies Veterinary Vaccines Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Application
- 8.2.2. By Country
8.3. North America: Country Analysis
- 8.3.1. United States Rabies Veterinary Vaccines Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Application
- 8.3.2. Mexico Rabies Veterinary Vaccines Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Application
- 8.3.3. Canada Rabies Veterinary Vaccines Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Application

9. South America Rabies Veterinary Vaccines Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Application
- 9.2.2. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Rabies Veterinary Vaccines Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Application
- 9.3.2. Argentina Rabies Veterinary Vaccines Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Application
- 9.3.3. Colombia Rabies Veterinary Vaccines Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Application

10. Middle East and Africa Rabies Veterinary Vaccines Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Application
- 10.2.2. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Rabies Veterinary Vaccines Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Application
- 10.3.2. Saudi Arabia Rabies Veterinary Vaccines Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Application
- 10.3.3. UAE Rabies Veterinary Vaccines Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Application
- 10.3.4. Egypt Rabies Veterinary Vaccines Market Outlook
  - 10.3.4.1. Market Size & Forecast
    - 10.3.4.1.1. By Value
  - 10.3.4.2. Market Share & Forecast
    - 10.3.4.2.1. By Application

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Recent Developments
12.2. Product Launches (If Any)
12.3. Mergers & Acquisitions (If Any)

13. Global Rabies Veterinary Vaccines Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Product

15. Competitive Landscape

15.1. Merck & Co., Inc. (MSD Animal Health)
- 15.1.1. Business Overview
- 15.1.2. Company Snapshot
- 15.1.3. Products & Services
- 15.1.4. Financials (As Reported)
- 15.1.5. Recent Developments
- 15.1.6. Key Personnel Details
- 15.1.7. SWOT Analysis
15.2. Indian Immunologicals Ltd.
15.3. Boehringer Ingelheim International GmbH (Animal Health)
15.4. Zoetis Inc.
15.5. Virbac S.A.
15.6. BroadChem Philippines Biopharma Corporation
15.7. Elanco Animal Health Inc.
15.8. Ceva Sante Animale S.A.
15.9. BiogenesisBago. S.A.
15.10. Sanofi SA

16. Strategic Recommendations

17. About Us & Disclaimer

02-2729-4219

+886-2-2729-4219

License/价格

狂犬病兽用疫苗市场 - 全球产业规模、份额、趋势、机会和预测，按应用（伴侣动物、家畜、野生动物）区域和竞争细分，2019-2029F

Rabies Veterinary Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application (Companion Animals, Livestock Animals, Wildlife Animals) Region and Competition, 2019-2029F

主要市场驱动因素

主要市场挑战

主要市场趋势

细分市场洞察

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第 4 章：客户之声

第 5 章：全球狂犬病兽用疫苗市场展望

第 6 章：亚太地区狂犬病兽用疫苗市场展望

第 7 章：欧洲狂犬病兽用疫苗市场展望

第 8 章：北美狂犬病兽用疫苗市场展望

第 9 章：南美洲狂犬病兽用疫苗市场展望

第 10 章：中东和非洲狂犬病兽用疫苗市场展望

第 11 章：市场动态

第 12 章：市场趋势与发展

第 13 章：全球狂犬病兽用疫苗市场：SWOT 分析

第 14 章：波特的五力分析

第15章：竞争格局

第 16 章：策略建议

第17章调查会社について・免责事项

Key Market Players

Report Scope:

Rabies Veterinary Vaccines Market, By Application:

Rabies Veterinary Vaccines Market, By Region:

Competitive Landscape

Available Customizations:

Company Information

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Global Rabies Veterinary Vaccines Market Outlook

6. Asia Pacific Rabies Veterinary Vaccines Market Outlook

7. Europe Rabies Veterinary Vaccines Market Outlook

8. North America Rabies Veterinary Vaccines Market Outlook

9. South America Rabies Veterinary Vaccines Market Outlook

10. Middle East and Africa Rabies Veterinary Vaccines Market Outlook

11. Market Dynamics

12. Market Trends & Developments

13. Global Rabies Veterinary Vaccines Market: SWOT Analysis

14. Porter's Five Forces Analysis

15. Competitive Landscape

16. Strategic Recommendations

17. About Us & Disclaimer